Speaker illustration

Miss Amelie Paasche

Heidelberg (Germany)

Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

Event: ESC Congress 2022

Topic: Cellular Mechanisms of Arrhythmias

Session: Insights into arrhythmia mechanisms

Thumbnail

This platform is supported by

logo Novo Nordisk